Population
34 angiosarcomas
Design
Cohort
Authors
Loading...
Low VEGFR-2 expression may identify higher-risk angiosarcoma; hypothesis-generating for biomarker validation, should not yet change practice.
Low or no VEGFR-2 expression in angiosarcomas is associated with a significantly unfavorable prognosis.
Itakura et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: